WallStreetZenWallStreetZen

NASDAQ: HBIO
Harvard Bioscience Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HBIO past revenue growth

How has HBIO's revenue growth performed historically?
Company
-0.96%
Industry
7.53%
Market
17.55%
HBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HBIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HBIO's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HBIO earnings and revenue history

Current Revenue
$112.3M
Current Earnings
-$3.4M
Current Profit Margin
-3%

HBIO Return on Equity

Current Company
-4.6%
Current Industry
11.1%
Current Market
188%
HBIO's Return on Equity (-4.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HBIO announces earnings.

HBIO Return on Assets

Current Company
-2.4%
Current Industry
7.2%
HBIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HBIO Return on Capital Employed

Current Company
0.93%
Current Industry
9.7%
HBIO has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HBIO vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HBIO$112.25M$8.03M-$3.42M-1.45%N/A
INFU$125.79M$16.53M$872.00k+13.38%-13.06%
AKYA$96.63M-$45.63M-$63.32M+22.99%N/A
STXS$26.77M-$20.09M-$22.06M-1.82%N/A
ZTEK$24.90k-$8.44M-$8.87M-58.51%N/A
View Top Medical Stocks

HBIO earnings dates

Next earnings date
May 14, 2024

Harvard Bioscience Earnings & Revenue FAQ

What were HBIO's earnings last quarter?

On Invalid Date, Harvard Bioscience (NASDAQ: HBIO) reported Q4 2023 earnings per share (EPS) of -$0.04, up 0% year over year. Total Harvard Bioscience earnings for the quarter were -$1.82 million. In the same quarter last year, Harvard Bioscience's earnings per share (EPS) was -$0.04.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.

What was HBIO's earnings growth in the past year?

As of Q2 2024, Harvard Bioscience's earnings has grown year over year. Harvard Bioscience's earnings in the past year totalled -$3.42 million.

What is HBIO's earnings date?

Harvard Bioscience's earnings date is Invalid Date. Add HBIO to your watchlist to be reminded of HBIO's next earnings announcement.

What was HBIO's revenue last quarter?

On Invalid Date, Harvard Bioscience (NASDAQ: HBIO) reported Q4 2023 revenue of $28.15 million up 0.96% year over year. In the same quarter last year, Harvard Bioscience's revenue was $28.43 million.

What was HBIO's revenue growth in the past year?

As of Q2 2024, Harvard Bioscience's revenue has grown -0.96% year over year. This is 8.48 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.53%. Harvard Bioscience's revenue in the past year totalled $112.25 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.